Billionaire Profile
K
Global Rank
#605

Image: Unknown Author | Public domain | via Wikimedia Commons

Katharina von Baumbach

CEO, Pharma
GERMANY
Real-Time Net Worth
$6.538B
Estimated based on Pharma stock value as of March 6, 2026
0% (24h)
Age
26
Source
Pharma
Industry
Healthcare
Citizenship
GERMANY

Biography

Katharina von Baumbach, born in Germany on October 2, 1999, is a prominent figure in the pharmaceutical industry, known for her inherited wealth from Boehringer Ingelheim. With an estimated net worth of $5.9 billion, she is a young, successful businesswoman. Her source of wealth is rooted in the pharmaceutical sector, reflecting the family's historical involvement in the industry. Katharina represents the fourth generation of her family managing the company's fortunes. Despite her youth, she holds a high ranking among global billionaires, marking her presence in the world of high finance.

Fact Checked
Verified by Editorial Team
Live Data
Updated 3/6/2026

Wealth Over Time

In-Depth Profile

Early Life

Katharina von Baumbach was born on October 2, 1999, in Germany. She is a member of the von Baumbach family, known for their deep roots in the pharmaceutical industry and their connection to Boehringer Ingelheim, a leading global pharmaceutical company. The family's history and wealth are intertwined with Boehringer Ingelheim, a company founded in 1885.

Rise to Success

Katharina's wealth and status come from her inheritance within Boehringer Ingelheim, a company known for its research-driven approach to healthcare. As an heir, she is part of the fourth generation of her family managing the company's fortunes. She is one of the youngest female billionaires in the pharmaceutical industry. Katharina's net worth has been estimated at around $5.9 billion as of February 2, 2026.

Key Business Strategies

Katharina is not known to hold an active executive role. The family's wealth is a result of their stake in the Boehringer Ingelheim fortune. The company's strategy centers on research and innovation in both human and animal health, with a focus on discovering, developing, and marketing innovative healthcare products. The company has a presence in 130 markets and employs 53,000 people.

Philanthropy

Specific philanthropy amounts are not readily available.

Career Milestones

2001

Joined Boehringer Ingelheim

Joined Boehringer Ingelheim as an heir to the family's fortune.

Philanthropy & Social Impact

Unknown

Not publicly available

Undisclosed

Information on specific philanthropic initiatives is not available.